Geneva: The World Health Organisation today said it will again add two HIV drugs from India`s Cipla in its prequalified list after they were delisted in May for non-compliance of standards."The World Health Organisation (WHO) is reinstating two antiretrovirals manufactured by Cipla Ltd, India, in its list of prequalified medicines," WHO said in its website.The two medicines were delisted by WHO in May this year due to non-compliance with international standards at the contract research organisations (CROs) hired by Cipla to conduct bioequivalence tests on the products, it said.
WHO`s prequalification programme aims to make quality medicines available for the benefit of those in need. This is achieved through its evaluation and inspection activities and by building national capacity for sustainable manufacturing and monitoring of quality medicines.The list of prequalified medicinal products used for HIV/AIDS, malaria, tuberculosis and for reproductive health produced by the programme is used principally by UnitedNations agencies, including UNAIDS and UNICEF to guide their procurement decisions.Reacting to the development, Cipla shares today moved up nearly 2 per cent and finally settled at 321.65 on Bombay Stock Exchange, up 1.48 per cent from its previous close. PTI